Timing clarification: P&G’s official announcement schedules the fiscal fourth-quarter earnings webcast for Wednesday, July 29, 2026, at 8:30 a.m. ET. Since today is July 29, the report is scheduled for today, not tomorrow. (us.pg.com)
This preview uses information available before the release, including results through fiscal Q3 and market data through July 28.
This report is less about whether P&G can clear a relatively low fourth-quarter EPS bar and more about whether management can credibly promise earnings growth in fiscal 2027 without sacrificing the investments supporting its recent sales improvement.
The operating picture improved materially in fiscal Q3: organic sales rose 3%, volume contributed two points, and every major category and geographic region posted growth. But Q3 also benefited from roughly one point of sales pulled forward from Q4, while tariffs, energy-linked inflation and increased brand spending pressured margins. Management subsequently said full-year EPS would likely finish near the bottom of its range. (pginvestor.com)
The most important items will therefore be:
| Metric | Current expectation | Comparison |
|---|---|---|
| Revenue | Approximately $21.4 billion | About +2.3% YoY |
| Core EPS | Approximately $1.41–$1.43 | Down roughly 3%–5% YoY |
| Organic sales growth | Approximately 2.1% | Q3 was +3% |
| Core gross margin | Approximately 48.4%–48.9% | Likely down YoY |
| Core operating margin | Approximately 20% | Likely down YoY |
| FY2026 core EPS | Approximately $6.88 | +0.7% versus FY2025 |
| FY2027 consensus EPS | Approximately $7.03 | About +2% versus FY2026 consensus |
Published estimates vary slightly by provider. Zacks has revenue of approximately $21.4 billion and EPS of $1.41, while other consensus feeds are around $1.42–$1.43. (zacks.com)
P&G generated $5.46 of core EPS during the first nine months, so the current $6.88 full-year consensus mathematically implies approximately $1.42 in Q4. That is consistent with management’s prior indication that FY2026 would land near the low end of its $6.83–$7.09 core-EPS range.
Fiscal 2026 has been uneven:
| Fiscal quarter | Organic sales | Volume | Core EPS growth |
|---|---|---|---|
| Q1 | +2% | Flat | +3% |
| Q2 | Flat | -1% | Flat |
| Q3 | +3% | +2% | +3% |
| Q4 consensus | About +2% | Not disclosed | Negative YoY |
The Q3 acceleration was broad rather than concentrated in one business:
However, management estimated that approximately one percentage point of volume shifted from Q4 into Q3, due primarily to Easter timing, prior-year inventory comparisons and some retailer inventory activity. Consequently, an organic-sales result near 2% may be perfectly acceptable if the underlying consumption and share data remain constructive.
This is the central top-line question.
P&G’s Q3 volume growth was its best signal of underlying improvement in several quarters. The gains were supported by product interventions such as upgraded Tide liquids, Tide evo, SK-II innovation and improved Beauty execution. Management also said global aggregate market share had returned to roughly flat year over year.
Investors should distinguish between:
A strong report would show positive organic volume despite the timing headwind, or at least stable volume accompanied by improved share. A weak report would show that Q3’s improvement was principally inventory- and comparison-driven.
Businesses to watch:
P&G typically provides full-year guidance with its June-quarter results. This year’s outlook is unusually difficult because management is planning against volatile energy prices, tariffs and supply-chain costs.
On the Q3 call, management estimated that an environment with Brent crude near $100 per barrel could create approximately $1.3 billion of annual pre-tax cost pressure, or roughly $1 billion after tax, compared with pre-conflict oil prices in the mid-$60s. The exposure extends beyond direct commodities to petrochemical feedstocks, transportation, alternative sourcing, reformulation and higher inventory requirements.
That creates a difficult fiscal 2027 bridge:
Potential offsets
Likely headwinds
The Street currently expects only about 2% EPS growth in FY2027, from roughly $6.88 to $7.03. Some analysts have moved below that level; for example, Bank of America recently reduced its FY2027 estimate to $6.88, citing a near-term mismatch between pricing and oil-related costs. (stage.zacks.com)
That means expectations already incorporate considerable pressure. A guide for positive low-single-digit core EPS growth with credible assumptions could be received reasonably well. A flat-to-down EPS outlook would likely shift attention toward the duration of the margin downturn.
P&G’s core gross margin fell 100 basis points in Q3. The drivers included:
Core operating margin fell 80 basis points despite substantial productivity savings. (pginvestor.com)
This presents an important distinction for investors:
Management has repeatedly said it will not cut support for businesses showing momentum merely to protect near-term margins. The call should reveal whether that commitment can coexist with earnings growth next year.
P&G does not appear to be planning broad, uniform price increases. Management’s preferred approach is selective pricing attached to products with demonstrably better performance.
This is sensible given cumulative consumer inflation, but it also means cost recovery may take longer than in previous inflationary cycles. Investors should listen for:
The ideal outcome is positive pricing without a return to material volume declines. If pricing rises but volume turns negative, the market may question the durability of organic growth.
Greater China grew 3% organically in Q3 despite a difficult local category environment. SK-II grew strongly, while China Baby Care also posted substantial gains.
The improvement appears to reflect changes in product innovation, digital marketing and channel execution rather than broad market recovery. That is encouraging because it implies company-specific share gains, but it also makes execution critical.
Investors should watch:
Continued low-to-mid-single-digit China growth would be a positive differentiator. A sharp reversal would raise questions about how repeatable the Q3 gains were.
P&G entered Q4 targeting:
Cash conversion was 82% in Q3 and 88% in Q2, after a stronger Q1. Higher capital spending, restructuring cash costs and inventory requirements are important variables for the full-year result.
The company is also executing a restructuring program intended to reduce nonmanufacturing headcount by approximately 15% over two years, simplify the portfolio and move decision-making closer to consumers. Investors should look for quantified savings, timing and any increase in restructuring charges.
P&G recently declared a quarterly dividend of $1.0885 per share, marking its 70th consecutive annual dividend increase. At the July 28 closing price, that equates to an annualized yield of approximately 2.9%.
PG closed July 28 at $148.91. At that price:
The valuation is not extreme for a defensive, high-quality consumer-staples company, but it still assumes that P&G can deliver at least modest earnings growth and protect long-term brand economics.
With FY2027 consensus growth at only about 2%, the setup is not especially demanding. However, the stock likely needs more than a small Q4 EPS beat: investors will want proof that volume momentum can survive pricing and that productivity can prevent an extended margin decline.
Interpretation: Q3’s acceleration was real, and P&G can absorb the cost shock without interrupting its balanced-growth model.
Interpretation: The business is improving, but earnings recovery will be gradual.
Interpretation: Q3 was more timing-driven than structural, and the new cost environment exposes a limited near-term earnings-growth path.
| Item | Constructive signal | Warning signal |
|---|---|---|
| Organic sales | ≥2%, with stable/positive volume | ≤1%, negative volume |
| Market share | Sequential improvement | Renewed broad-based losses |
| North America | Consumption-led growth | Inventory-driven growth only |
| China | Continued low-to-mid-single-digit growth | Return to decline |
| Beauty | Sustained strong growth | Sharp deceleration |
| U.S. Baby Care | Early share improvement | Continued deterioration |
| Core gross margin | Better than roughly -50 bps | Down more than 100 bps |
| FY2027 EPS | Positive growth with credible bridge | Flat/down or very wide range |
| Pricing | Selective, innovation-led, manageable elasticity | Broad pricing with volume risk |
| Cash flow | FY2026 productivity within 85%–90% | Miss or lowered medium-term expectations |
| Investment | Maintained behind winning businesses | Material cuts to defend EPS |
The Q4 numbers themselves carry a manageable bar: roughly 2% organic growth, $21.4 billion of revenue and $1.42 of core EPS. A modest beat or miss around those figures should not determine the investment conclusion.
The more consequential question is whether P&G can present a credible fiscal 2027 plan that combines:
A clean Q4 accompanied by positive FY2027 EPS growth would support the view that P&G’s recent top-line recovery is gaining durability. Conversely, weak underlying volume or flat-to-down FY2027 guidance would suggest that the company’s premium valuation and defensive reputation are being tested by a more difficult price-cost environment.